These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27122793)

  • 1. Long-Term Survival of Multicenter Automatic Defibrillator Implantation Trial (MADIT) II-Eligible Patients in Taiwan.
    Chang PC; Chen WT; Wo HT; Chen TH; Wen MS; Yeh SJ; Wang CC
    Acta Cardiol Sin; 2014 May; 30(3):229-35. PubMed ID: 27122793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of outcome of Indian patients who meet MADIT II (Multicenter Automatic Defibrillator Implantation Trial) criteria for implantable cardioverter defibrillator implantation: is it appropriate for Indian patients?
    Yadav R; Chandra A; Yadav G; Naik N
    Indian Heart J; 2020; 72(3):172-178. PubMed ID: 32768016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
    Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
    Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria.
    An Y; Ando K; Soga Y; Nomura A; Nagashima M; Hayashi K; Makihara Y; Fukunaga M; Hiroshima KI; Nobuyoshi M; Goya M
    J Arrhythm; 2017 Feb; 33(1):17-22. PubMed ID: 28217224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients?
    Tanno K; Miyoshi F; Watanabe N; Minoura Y; Kawamura M; Ryu S; Asano T; Kobayashi Y; Katagiri T;
    Circ J; 2005 Jan; 69(1):19-22. PubMed ID: 15635196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.
    Sharma PP; Greenlee RT; Anderson KP; Chyou PH; Osorio HJ; Smith PN; Hayes JH; Vidaillet H
    J Interv Card Electrophysiol; 2007 Sep; 19(3):157-64. PubMed ID: 17805953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator.
    Uslu A; Dogan C; Duman H; Tanboga IH; Askin L; Sevimli S
    North Clin Istanb; 2019; 6(1):40-47. PubMed ID: 31180377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
    Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
    Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators.
    Cygankiewicz I; Gillespie J; Zareba W; Brown MW; Goldenberg I; Klein H; McNitt S; Polonsky S; Andrews M; Dwyer EM; Hall WJ; Moss AJ;
    Heart Rhythm; 2009 Apr; 6(4):468-73. PubMed ID: 19324304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Multicenter Automatic Defibrillator Implantation Trial II risk score in a nontrial setting.
    Naksuk N; Akkaya M; Adabag S
    Am J Cardiol; 2013 Aug; 112(4):530-2. PubMed ID: 23672992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
    J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.
    Biton Y; Rosero S; Moss A; Zareba W; Kutyifa V; Baman J; Barsheshet A; McNitt S; Polonsky B; Goldenberg I
    Am J Cardiol; 2018 Mar; 121(5):615-620. PubMed ID: 29307459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.